PERKINS CAPITAL MANAGEMENT INC

Position in CELC — Celcuity Inc.

CIK 884300 WAYZATA, MN

Position in CELC

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$470,790

-$145,566 QoQ

Shares Held

4,500

-16.7% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#29

of 64 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 64% Shared 0% None 36%

Healthcare · as of Jun 30, 2026

PERKINS CAPITAL MANAGEMENT INC holds $2,091,815 across 5 Biotechnology names. CELC ranks #2 (22.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CDXS	Codexis, Inc.	526,100	$1,188,986
2	CELC	Celcuity Inc. This page	4,500	$470,790
3	MRNA	Moderna, Inc.	4,000	$280,120
4	PBYI	Puma Biotechnology, Inc.	13,400	$108,674
5	DYAI	Dyadic International Inc	48,050	$43,245

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$470,790	4,500	-16.7%	Shares	Sole	2026-07-24
2026-03-31	$616,356	5,400	-15.6%	Shares	Sole	2026-04-23
2025-12-31	$638,336	6,400	-19.0%	Shares	Sole	2026-02-04
2025-09-30	$390,260	7,900	-32.5%	Shares	Sole	2025-10-31
2025-06-30	$156,195	11,700	+3.1%	Shares	Sole	2025-08-07
2025-03-31	$114,748	11,350	—	Shares	Sole	2025-05-07
No filing history on record for this holder in this stock.